Protective effect of puerarin on rats with alcoholic hepatitis

World Chinese Journal of Digestology

Volumn 17, Issue 7, 2009, Pages 657-661

  Qu, Zhi Wei ^a   Wen, Chun Yang ^a   Wang, Ai Ping ^a   Ju, Wen Bo ^a   Ren, Ai Hua ^a   Liu, Mao Yang ^a   Zhou, Yan ^a  

^a BEIHUA UNIVERSITY   (China)

Author keywords

Alcoholic hepatitis; Cyclooxygenase type 2; Interleukin 6; Prostaglandin E2; Puerarin; Tumor necrosis factor

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; INTERLEUKIN 6; PROSTAGLANDIN E2; PUERARIN; TUMOR NECROSIS FACTOR ALPHA;

ALCOHOL LIVER DISEASE; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; MICROSCOPY; NONHUMAN; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING;

EID: 68949146761     PISSN: 10093079     EISSN: None     Source Type: Journal    
DOI: 10.11569/wcjd.v17.i7.657     Document Type: Article

References (24)

1. David AB. Sigmund S. pathogenesis of alcoholic hepatitis, J Gastroenterol Hepatol 2004; 19: S229-S235
2. Reuben A. Alcohol and the liver. Curr Opin Gastroenterol 2007; 23: 283-291
3. Irie M, Suzuki N, Sohda T, Anan A, Iwata K, Takeyama Y, Watanabe H, Fischer P, Scherberich JE, Sakisaka S. Hepatic expression of gamma-glutamyltranspeptidase in the human liver of patients with alcoholic liver disease. Hepatol Res 2007; 37: 966-973 (Pubitemid 47399926)
4. Day CP. Treatment of alcoholic liver disease. Liver Transpl 2007; 13: S69-S75
5. Nagata K, Suzuki H, Sakaguchi S. Common pathogenic mechanism in development progression of liver injury caused by non-alcoholic or alcoholic steatohepatitis. J Toxicol Sci 2007; 32: 453-468
6. Tome S, Lucey MR. Review article: current management of alcoholic liver disease. Aliment Pharmacol Ther 2004; 19: 707-714 (Pubitemid 38496636)
7. Zhang SY, Chen G, Wei PF, Huang XS, Dai Y, Shen YJ, Chen SL, Sun-Chi CA, Xu HX. The effect of puerarin on serum nitric oxide concentration and myocardial eNOS expression in rats with myocardial infarction. J Asian Nat Prod Res 2008; 10: 373-381
8. Ding MP, Feng F, Hu HT. [Effects of puerarin on expression of nuclear factor kappaB after cerebral ischemia/reperfusion in rats] Zhongguo Zhongyao Zazhi 2007; 32: 2515-2518
9. Tan Y, Liu M, Wu B. Puerarin for acute ischaemic stroke. Cochrane Database Syst Rev 2008: CD004955
10. 2+] Zhongguo Zhongyao Zazhi 2007; 32: 2058-2062
11. Hwang YP, Choi CY, Chung YC, Jeon SS, Jeong HG. Protective effects of puerarin on carbon tetrachloride-induced hepatotoxicity. Arch Pharm Res 2007; 30: 1309-1317
12. Singh AK, Jiang Y, Benlhabib E, Gupta S. Herbal mixtures consisting of puerarin and either poly enylphosphatidylcholine or curcumin provide comprehensive protection against alcohol-related disorders in P rats receiving free choice water and 15% ethanol in pure water. J Med Food 2007; 10: 526-542 (Pubitemid 47493501)
13. Samaka RM, Abdou AG, Abd El-Wahed MM, Kandil MA, El-Kady NM. Cyclooxygenase-2 expression in chronic gastritis and gastric carcinoma, correlation with prognostic parameters. J Egypt Natl Canc Inst 2006; 18: 363-374
14. Harada N, Okajima K, Uchiba M, Kushimoto S, Isobe H. Antithrombin reduces ischemia/reperfusion-induced liver injury in rats by activation of cyclooxygenase-1. Thromb Haemost 2004; 92: 550-558 (Pubitemid 39248011)
15. Warford-Woolgar L, Peng CY, Shuhyta J, Wakefield A, Sankaran D, Ogborn M, Aukema HM. Selectivity of cyclooxygenase isoform activity and prostanoid production in normal and diseased Han:SPRD-cy rat kidneys. Am J Physiol Renal Physiol 2006; 290: F897-F904 (Pubitemid 43724952)
16. Bykov IL, Palmen M, Rainsford KD, Lindros KO. Chronic effects of celecoxib, a cyclooxygenase-2 inhibitor, cause enhanced alcohol-induced liver steatosis in rats. Inflammopharmacology 2006; 14: 36-41
17. Nanji AA, Jokelainen K, Lau GK, Rahemtulla A, Tipoe GL, Polavarapu R, Lalani EN. Arginine reverses ethanol-induced inflammatory and fibrotic changes in liver despite continued ethanol administration. J Pharmacol Exp Ther 2001; 299: 832-839 (Pubitemid 33104949)
18. Senthilkumar R, Nalini N. Effect of glycine on tissue fatty acid composition in an experimental model of alcohol-induced hepatotoxicity. Clin Exp Pharmacol Physiol 2004; 31: 456-461 (Pubitemid 39044127)
19. Saravanan N, Nalini N. Antioxidant effect of Hemidesmus indicus on ethanol-induced hepatotoxicity in rats. J Med Food 2007; 10: 675-682
20. Tipoe GL, Liong EC, Casey CA, Donohue TM Jr, Eagon PK, So H, Leung TM, Fogt F, Nanji AA. A voluntary oral ethanol-feeding rat model associated with necroinflammatory liver injury. Alcohol Clin Exp Res 2008; 32: 669-682
21. Irie M, Suzuki N, Sohda T, Anan A, Iwata K, Takeyama Y, Watanabe H, Fischer P, Scherberich JE, Sakisaka S. Hepatic expression of gamma-glutamyltranspeptidase in the human liver of patients with alcoholic liver disease. Hepatol Res 2007; 37: 966-973 (Pubitemid 47399926)
22. Izu H, Shobayashi M, Manabe Y, Goto K, Iefuji H. Sake yeast suppresses acute alcohol-induced liver injury in mice. Biosci Biotechnol Biochem 2006; 70: 2488-2493 (Pubitemid 44656416)
23. Cui JW, Hu YY, Fang ZH, Wang XN, Cheng Y, Jing-Hua P, Feng Q, Hui Z. Intervention effects of Jianpi Liqi Huoxue Decoction on lipid peroxidative liver injury induced by alcohol. Chin J Integr Med 2006; 12: 281-286 (Pubitemid 46087143)
24. Pari L, Karthikesan K. Protective role of caffeic acid against alcohol-induced biochemical changes in rats. Fundam Clin Pharmacol 2007; 21: 355-361 (Pubitemid 47084030)